Publisher: Elsevier

Related content
Volume 46, Number 2, 15 December 2000

< previous issue | all issues | next issue >

Favourites:Add to Favourites

Improvement in cognition associated with novel antipsychotic drugs: a direct drug effect or reduction of EPS?
pp. 81-89(9)
Authors: Weiser, M.; Shneider-Beeri, M.; Nakash, N.; Brill, N.; Bawnik, O.; Reiss, S.; Hocherman, S.; Davidson, M.

Favourites:Add to Favourites

Comparison of cost, dosage and clinical preference for risperidone and olanzapine
pp. 91-96(6)
Authors: Rabinowitz, J.; Lichtenberg, P.; Kaplan, Z.

Favourites:Add to Favourites

Reemergence of tardive dyskinesia after discontinuation of clozapine treatment
pp. 107-109(3)
Authors: Yovtcheva, S.P.; Stanley-Tilt, C.; Moles, J.K.

Favourites:Add to Favourites

Zuclopenthixol acetate in psychiatric emergencies: looking for evidence from clinical trials
pp. 111-118(8)
Authors: Coutinho, E.; Fenton, M.; Adams, C.; Campbell, C.

Favourites:Add to Favourites

Effects of smoking during antipsychotic withdrawal in patients with chronic schizophrenia
pp. 119-127(9)
Authors: Apud, J.A.; Egan, M.F.; Wyatt, R.J.

Favourites:Add to Favourites

Practice-related improvement in information processing with novel antipsychotic treatment
pp. 139-148(10)
Authors: Harvey, P.D.; Moriarty, P.J.; Serper, M.R.; Schnur, E.; Lieber, D.

Favourites:Add to Favourites

A new look at reaction time in schizophrenia
pp. 149-165(17)
Authors: Gale, H.J.; Holzman, P.S.

Favourites:Add to Favourites

Schizophrenia patients demonstrate a dissociation on declarative and non-declarative memory tests
pp. 167-174(8)
Authors: Perry, W.; Light, G.A.; Davis, H.; Braff, D.L.

Favourites:Add to Favourites

Event-related potentials in a working-memory task in schizophrenics and controls
pp. 175-186(12)
Authors: Low, A.; Rockstroh, B.; Harsch, S.; Berg, P.; Cohen, R.

Favourites:Add to Favourites

Memory for temporal order in patients with schizophrenia
pp. 187-193(7)
Authors: Elvevag, B.; Egan, M.F.; Goldberg, T.E.

Favourites:Add to Favourites

Reaction time, symptom profiles and course of illness in schizophrenia
pp. 195-201(7)
Authors: Ngan, E.T.C.; Liddle, P.F.

Favourites:Add to Favourites

IQ scores of treatment-resistant schizophrenia patients before and after the onset of the illness
pp. 203-207(5)
Authors: Sheitman, B.B.; Murray, M.G.; Snyder, J.A.; Silva, S.; Goldman, R.; Chakos, M.; Volavka, J.; Lieberman, J.A.

Favourites:Add to Favourites

Short form of the WAIS-III for use with patients with schizophrenia
pp. 209-215(7)
Authors: Blyler, C.R.; Gold, J.M.; Iannone, V.N.; Buchanan, R.W.

Favourites:Add to Favourites

Modification of affect perception deficits in schizophrenia
pp. 217-229(13)
Authors: Penn, D.L.; Combs, D.

Favourites:Add to Favourites
Favourites:Add to Favourites

Is the attentional dysfunction in schizotypy related to anxiety?
pp. 255-267(13)
Author: Braunstein-Bercovitz, H.

Favourites:Add to Favourites

Executive/attentional performance and measures of schizotypy in patients with schizophrenia and in their nonpsychotic first-degree relatives
pp. 269-283(15)
Authors: Laurent, A.; Biloa-Tang, M.; Bougerol, T.; Duly, D.; Anchisi, A.; Bosson, J.; Pellat, J.; d'Amato, T.; Dalery, J.

Favourites:Add to Favourites

a-b ridge count and schizophrenia
pp. 285-286(2)
Authors: Rosa, A.; Marcelis, M.; Fananas, L.; van Os, J.

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more